SERUM ALBUMIN LEVELS AS A PROGNOSTIC MARKER IN ARTERIOVENOUS FISTULA FAILURE IN CHRONIC KIDNEY DISEASE PATIENTS IN A TERTIARY CARE CENTRE – A CROSS SECTIONAL STUDY
Genetics and Molecular Research · 27.07.2026
DOI: 10.4238/5bmtb107 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genetics and Molecular Research, online erschienen am 27.07.2026. Verfasst von Dr M Aravind Venkat und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
CKD is a significant community well-being concern in developing nations like India, where late diagnosis and insufficient resources result in unfavourable outcomes. Hemodialysis constitutes the primary renal replacement treatment, and arteriovenous fistulas (AVFs) are the optimal vascular access because of improved patency and reduced complications. Nevertheless, up to 40 per cent of patients have AVF failure due to poor maturation or early dysfunction. Negative acute phase proteins like serum albumin indicate the nutritional and inflammatory conditions in CKD. Hypoalbuminemia is frequent because of malnutrition, inflammation and protein losses, and is linked to poor tissue repair, endothelial dysfunction and poor vascular integrity, which can have negative implications on AVF outcomes.
Zitieren
APA
Venkat, D. M. A., A, D. R., & N, D. P. K. (2026). SERUM ALBUMIN LEVELS AS A PROGNOSTIC MARKER IN ARTERIOVENOUS FISTULA FAILURE IN CHRONIC KIDNEY DISEASE PATIENTS IN A TERTIARY CARE CENTRE – A CROSS SECTIONAL STUDY. Genetics and Molecular Research. https://doi.org/10.4238/5bmtb107
Vancouver
Venkat DMA, A DR, N DPK. SERUM ALBUMIN LEVELS AS A PROGNOSTIC MARKER IN ARTERIOVENOUS FISTULA FAILURE IN CHRONIC KIDNEY DISEASE PATIENTS IN A TERTIARY CARE CENTRE – A CROSS SECTIONAL STUDY. Genetics and Molecular Research. 2026. doi:10.4238/5bmtb107
BibTeX
@article{Venkat2026,
author = {Venkat, Dr M Aravind and A, Dr Raveesha and N, Dr Prasanna Kumar},
title = {SERUM ALBUMIN LEVELS AS A PROGNOSTIC MARKER IN ARTERIOVENOUS FISTULA FAILURE IN CHRONIC KIDNEY DISEASE PATIENTS IN A TERTIARY CARE CENTRE – A CROSS SECTIONAL STUDY},
journal = {Genetics and Molecular Research},
year = {2026},
doi = {10.4238/5bmtb107}
}
EUVIMED